07
22
2015
We most often think of bacteria as tiny imperceptible organisms that often cause us to become irritatingly sick or as the origin of terrible disease epidemics. At best, some may view microbes as quasi-helpful when they are packaged in the form of probiotic food or supplement. What if, however, we were able to use bacterial species as a diagnostic tool to detect disease?
07
22
2015
Agenus said today that Merck & Co. has extended their year-old, approximately $100 million-plus collaboration for the discovery and development of therapeutic antibodies against undisclosed Merck immune checkpoints for cancer.
07
21
2015
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials. One therapy is a vaccine that targets a structure on the outside of cancer cells, while the other is an altered enzyme that breaks apart RNA and causes the cell to commit suicide.
07
20
2015
Scientists generated new antibodies that tag essential chemicals involved in protein formation. In this dividing cell, the new antibody marks discrete areas of a critical chemical reaction that occurs when cells divide.
07
17
2015
Pfizer’s Centers for Therapeutic Innovation (CTI) and the Jeffrey Modell Foundation (JMF) have agreed to collaborate intended to advance research into immunological diseases.
